S Aizawa

Summary

Affiliation: Tokyo Medical and Dental University
Country: Japan

Publications

  1. ncbi Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector
    M Kitagawa
    Department of Pathology and Immunology, Faculty of Medicine, Tokyo Medical and Dental University, Japan
    Exp Hematol 27:234-41. 1999
  2. ncbi Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain
    M Kitagawa
    Department of Pathology and Immunology, Faculty of Medicine, Tokyo Medical and Dental University, Japan
    Exp Hematol 24:1423-31. 1996
  3. ncbi A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts
    M Kitagawa
    Department of Pathology and Immunology, Aging and Developmental Sciences, Tokyo Medical and Dental University, Graduate School, Japan
    Leukemia 15:1779-84. 2001
  4. ncbi Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia
    S Yamaguchi
    Department of Pathology and Immunology, Aging and Developmental Sciences, Faculty of Medicine, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    Mech Ageing Dev 122:219-32. 2001
  5. ncbi In vivo distribution of receptor for ecotropic murine leukemia virus and binding of envelope protein of Friend Murine leukemia virus
    S Yamaguchi
    Department of Pathology and Immunology, Aging and Developmental Sciences, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan
    Arch Virol 148:1175-84. 2003

Collaborators

Detail Information

Publications5

  1. ncbi Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector
    M Kitagawa
    Department of Pathology and Immunology, Faculty of Medicine, Tokyo Medical and Dental University, Japan
    Exp Hematol 27:234-41. 1999
    ..Thus, gene therapy model by transducing Fv-4r env gene using bone marrow transplantation would provide a useful protection model system of retrovirus-induced diseases...
  2. ncbi Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain
    M Kitagawa
    Department of Pathology and Immunology, Faculty of Medicine, Tokyo Medical and Dental University, Japan
    Exp Hematol 24:1423-31. 1996
    ....
  3. ncbi A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts
    M Kitagawa
    Department of Pathology and Immunology, Aging and Developmental Sciences, Tokyo Medical and Dental University, Graduate School, Japan
    Leukemia 15:1779-84. 2001
    ..These chimeras also resisted FLV-induced leukemogenesis, indicating that receptor interference-based gene therapy could become a therapeutic basis for immunodeficiency virus-induced diseases in vivo...
  4. ncbi Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia
    S Yamaguchi
    Department of Pathology and Immunology, Aging and Developmental Sciences, Faculty of Medicine, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    Mech Ageing Dev 122:219-32. 2001
    ..Discussion was made on the possible implication of these findings on the role of T cells in age-related change of resistance to FLV-induced leukemogenesis...
  5. ncbi In vivo distribution of receptor for ecotropic murine leukemia virus and binding of envelope protein of Friend Murine leukemia virus
    S Yamaguchi
    Department of Pathology and Immunology, Aging and Developmental Sciences, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan
    Arch Virol 148:1175-84. 2003
    ....